All Episodes

August 30, 2023 49 mins

In this episode, Professr Valerie Curran, discusses the psychological effects of drugs that act on the human brain. 

Valerie Curren holds the position of Professorial Fellow in the Neuroscience of Addiction and Mental Health Program at ACU's Healthy Brain and Mind Research Centre. She has an esteemed background as an Emeritus Professor of Psychopharmacology at University College London (UCL), having established the UCL Clinical Psychopharmacology Unit in 1996. Furthermore, she is a founding member of the charity Drug Science and serves as an advisor to the UK All Party Parliamentary Group on Drug Policy Reform.

Tune in to learn about her latest research into the short- and long-term effects of psychoactive drugs on mental health, cognition, memory and the brain as well as how CBD combined with psychological therapy may aid the treatment of cannabis use disorder.

Benzos

MDMA

Alcohol

Cannabis

CBD

THC

Ketamine

MDMA midweek blues paper – in journal Addiction (mid 90s) 

Inappropriate benzodiazepine use in elderly patients and its reduction 

Combined and individual effects of CBD and THC on memory

David Nutt and Psilocybin in Australia  

Cannabis potency

CBD treating clinical psychosis

CBD in treating cannabis use disorder

Project 2021

Medical cannabis reducing opiate use

Jon snow takes cannabis 

Endocannabinoid system

Support the podcast

★ Support this podcast ★
Mark as Played

Advertise With Us

Popular Podcasts

Dateline NBC
The Nikki Glaser Podcast

The Nikki Glaser Podcast

Every week comedian and infamous roaster Nikki Glaser provides a fun, fast-paced, and brutally honest look into current pop-culture and her own personal life.

Stuff You Should Know

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2024 iHeartMedia, Inc.